FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to the pharmaceutical industry and represents a water-free gel-like composition of mupirocin or its pharmaceutically acceptable salt for local application for the treatment of bacterial skin infections, containing a lipophilic base, selected from the group, consisting of vaseline, medium-chain triglycerides, isopropylmyristate and their mixtures, a bioadhesive, selected from the group, consisting of polyvinylpyrrolidone and polymethacrylates, and a solvent, selected from the group, consisting of ethanol, propanol and isopropanol.
EFFECT: provided is an increased time of the active ingredient presence in skin, which results in the reduction of the number of applications with the preservation of the clinical effect, as well as provides more effective treatment.
35 cl, 1 dwg, 8 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIOADHESIVE COMPOSITION (VARIANTS), METHOD FOR ITS PREPARING, DEVICE FOR DELIVERY OF ACTIVE AGENT THROUGH MUCOSA, METHOD FOR PROLONGED TOPICAL ADMINISTRATION OF ONE OR MORE ACTIVE AGENTS TO PATIENT (VARIANTS) AND METHOD FOR REDUCING TIME REQUIRED FOR STICKING COMPOSITION TO MUCOSA TISSUE | 1998 |
|
RU2234337C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ELECTROHYDRODYNAMICALLY PRODUCED FIBERS, COMPOSITION HAVING IMPROVED RETENTION TIME AT SITE OF USE | 2016 |
|
RU2701513C2 |
| GEL COMPOSITIONS | 2013 |
|
RU2677892C2 |
| DOSAGE FORMS CONTAINING DOPAMINE AGONISTS FOR PARENTERAL ADMINISTRATION | 2009 |
|
RU2532347C2 |
| SOLID NANOCOMPOSITION FOR DELIVERY OF BIOLOGICALLY ACTIVE SUBSTANCES | 2007 |
|
RU2351352C2 |
| LOCAL COMPOSITION CONTAINING AMBROXOL | 2005 |
|
RU2381794C2 |
| COMPOSITIONS COMPRISING ELECTROHYDRODYNAMICALLY PRODUCED FIBERS FOR APPLYING GIVEN DOSES OF THE ACTIVE SUBSTANCE TO THE SKIN OR MUCOSA | 2015 |
|
RU2695217C2 |
| BIODEGRADABLE PLASTER | 2008 |
|
RU2460519C2 |
| PHARMACEUTICAL COMPOSITIONS | 2010 |
|
RU2589699C2 |
| COMPOSITIONS FOR PERCUTANEOUS ADMINISTRATION | 2009 |
|
RU2497506C2 |
